Copyright
©The Author(s) 2022.
World J Hepatol. Apr 27, 2022; 14(4): 744-753
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.744
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.744
Table 1 Table summarizing the distribution of patients over fibrosis stages and their corresponding percentages
| Stage of fibrosis | Number of patients (%) |
| F0 | 29 (40) |
| F0-F1 | 13 (18) |
| F2-F3 | 14 (19) |
| F3-F4 | 5 (7) |
| F4 | 12 (16) |
| Total | 73 (100) |
- Citation: Al Danaf L, Hussein Kamareddine M, Fayad E, Hussain A, Farhat S. Correlation between Fibroscan and laboratory tests in non-alcoholic fatty liver disease/non-alcoholic steatohepatitis patients for assessing liver fibrosis. World J Hepatol 2022; 14(4): 744-753
- URL: https://www.wjgnet.com/1948-5182/full/v14/i4/744.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i4.744